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Background: Benefits of cardiac resynchronisation therapy (CRT) in patients with heart failure (HF) and left bundle branch block (LBBB)
have been well established. The presence of asynchronism and viability predicts response to CRT with good accuracy. Viability in the region
of the pacing lead as predictor of response to CRT in patients with HF, intraventricular asynchrony and right bundle branch block (RBBB)
has never been evaluated.
Methods: We studied 4 consecutive patients with RBBB (QRSN120 ms) advanced ischemic HF, low ejection fraction (≤35%) and
intraventricular asynchrony ≥50 ms scheduled for CRT. Dobutamine stress echocardiography (DSE) was performed within the week before
CRT. Viability was defined as increased wall thickening during DSE. Viability in the region of left ventricular (LV) pacing lead was defined
as the presence of viability in 2 contiguous segments. Response was defined by LV reverse remodeling (i.e. ≥15% reduction in LV end-
systolic volume) 3–6 months after CRT.
Results: Three patients demonstrated LV reverse remodeling at follow-up. Responders showed LVend-systolic volume decrease of −31±16%
from baseline to follow-up whereas no change was observed in the non responder patient. Similar LVasynchronism was found in all patients.
All responders had viability in ≥2 segments in the region of LV pacing.
Conclusion: This preliminary report suggests that similar reverse remodeling can be observed in RBBB patients as patients with LBBB after
CRT. Intraventricular asynchrony and RBBB, viability in the region of pacing lead may help to predict response to CRT in patients with HF.
© 2008 Elsevier Ireland Ltd. All rights reserved.Keywords: CRT; RBBB; Asynchronism; Viability1. Introduction
ACC/AHA Guidelines recommended cardiac resynchroni-
zation therapy (CRT) in patients with heart failure (HF) with
New York Heart Association (NYHA) class III to IV, low
ejection fraction (≤35%) and QRS duration N120 ms,
regardless of intraventricular delay pattern [1]. Despite these⁎ Corresponding author. Institut de Cardiologie de Québec, Hôpital Laval,
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to CRT [2]. Over 90% of patients enrolled in CRTstudies have
left bundle branch block (LBBB). In those patients, LV
dyssynchrony helps to predict response to CRT [3]. Presence
of viability has also gained growing acceptance as a predictor
of response to CRT in patients with HF [2,4–6].
Less than 10% of patients with advanced systolic HF and
abnormal ventricular conduction have RBBB. Consequently,
patients with RBBB represent a small proportion of patients
enrolled in CRT studies and limited data are available in this
particular population [7]. In 2001, Garrigue et al. showed in
12 patients that only patients with RBBB associated withisation therapy in patients with right bundle branch block: Is viability an
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Table 1
Population demographic and echocardiographic characteristics
Patient 1 Patient 2 Patient 3 Patient 4
Age (years) 77 68 81 73
Sex (M/F) M F F M
NYHA pre CRT III III III III
NYHA post CRT II II II III
QRS (ms) 172 150 164 150
LV asynchronism (ms) 80 75 160 135
LVEF pre CRT (%) 28 23 23 19
LVEF post CRT (%) 33 28 51 19
ERO pre CRT (mm2) – 18 10 –
ERO post CRT (mm2) – 13 8 –
Akinetic segments rest (n) 9 8 10 8
Akinetic segments dobu (n) 8 8 7 8
WMSI rest 3.6 3.3 2.6 3.2
WMSI dobu 3.1 2.7 2.3 3.1
Viable segments (n) 6 6 4 1
≥4 viable segments (y/n) Yes Yes Yes No
Viability pacing lead (y/n) Yes Yes Yes No
LVSV rest (ml) 171 200 150 172
LVSV follow up (ml) 119 170 80 174
LVSV reduction (%) 30 15 47 –
NYHA: New York Heart Association; CRT: cardiac resynchronization
therapy; LV: left ventricular; LVEF: left ventricular ejection fraction; ERO:
effective regurgitant orifice; WMSI: wall motion score index; LVSV: left
ventricular systolic volume.
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CRT [8]. However recently, Egoavil et al. analyzed the
combined results of MIRACLE and Contak CD trials, which
provided the largest cohort of patients with RBBB and HF
[9]. With the exception of NYHA class, patients in these
trials did not derive any clear significant benefit from CRT.
Authors, thereby, concluded that there is few data supporting
the use of CRT in patients with RBBB. Since RBBB was
proved to be an important predictor of mortality in HF
patients as much as LBBB, it seems important to clarify the
place of CRT in patients with RBBB and HF. Numerous
small studies have evaluated the presence of viability as a
predictor of response to CRT in ischemic and non ischemic
failing hearts [5,6]. Long term response to CRT may be
explained by the presence of myocardial viability in patients
with LV dysfunction. Moreover, presence of viability in the
region of the pacing lead has been recently showed to be a
predictor of acute response to CRT [10]. This factor has
never been evaluated in patients with RBBB. This
preliminary report describes our experience in such patients.
2. Methods
From June 2006 to September 2007, we studied 4
consecutive patients with RBBB underwent CRT implanta-
tion. The study was approved by our local ethics committee.
Inclusion criteria were as follow: (1) RBBB (QRSN120 ms),
(2) NYHA functional class III and IV, (3) chronic LV systolic
dysfunction (LV ejection fraction ≤35%), (4) basal LV
dyssynchrony ≥50 ms, and (5) optimal medical treatment
for HF including angiotensin-converting enzyme inhibitors
or AT1 receptor antagonists diuretics, beta-receptor blockers
and spironolactone when tolerated. Patients with recent
myocardial infarction (b6 months), coronary revasculariza-
tion procedure (b6 months) and presenting standard contra-
indications to DSE were excluded. All patients provided
informed consent and were prospectively enrolled. One day
after CRT implantation, the LV lead position was assessed
from a chest X-ray. Using lateral views (anterior, lateral or
posterior), we determined the LV lead location. Standard 2-
dimensional echocardiography studies were performed
within the week before CRT implantation. Echocardio-
graphic measurements were performed by two observers
blinded to patient's status using Philips Sonos 5500 or 7500
instrument with a 2.5-MHz transducer (Philips Medical
Systems, Amsterdam, The Netherlands). LV volumes and
ejection fraction were measured using the modified biplane
Simpson's rule. Proximal isovelocity surface area (PISA)
method was used to assess MR severity and to measure the
effective regurgitant orifice (ERO) area. Intraventricular
delay tissue Doppler imaging (TDI) was performed from
apical view analyzing septal, inferior, lateral, posterior and
anterior walls. Intraventricular electromechanical asyn-
chrony was defined as the time between the shortest and
the longest electromechanical delays among the five walls.
Interventricular electromechanical asynchrony was definedPlease cite this article as: O'Connor K, et al, Usefulness of cardiac resynchron
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delays. All patients underwent DSE according to a low-dose
infusion protocol. Patients received 5, 10, 15, and 20 µg/kg/
min of dobutamine in 3-minute stage, with echocardio-
graphic images recorded at each stage [11,12]. Heart rate and
blood pressure were monitored during each stage. Criteria
for stopping the dobutamine infusion included (1) hypoten-
sion (systolic blood pressure b90 mmHg), (2) angina, (3)
significant arrhythmias (atrial fibrillation, bigeminy, ventri-
cular tachycardia), (4) attainment of 85% maximal predicted
heart rate. The regional wall motion was assessed by the 16-
segments model recommended by the American Society of
Echocardiography [13]. Thus, a normal or hyperkinetic
segment was graded as 1, mild hypokinetic as 2, severe
hypokinetic as 3, akinetic as 4. Stress images during
dobutamine infusion showing the maximum augmentation
of wall motion were compared to baseline images. A
segment was considered to have contractile reserve if the
wall motion improved by one grade during DSE. Viability in
the region of the LV pacing lead was defined as the presence
of viability in 2 contiguous segments. Response to CRTwas
defined by evidence of LV reverse remodeling (≥15%
reduction in LVend-systolic volume) 3–6 months after CRT.
3. Results
Table 1 lists the individual baseline characteristics of
enrolled patients. The four patients (mean age 75±6 years, 2
males) had ischemic HF, were in sinus rhythm and NYHA
functional III. MR was observed in 2 patients (meanisation therapy in patients with right bundle branch block: Is viability an
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CRT. In these patients, mean LV end-systolic volume
decreased was 31±16% (from 174±25 ml to 123±45 ml).
There was no change in LV end-systolic volume in the non
responder patient. With regard to LV asynchronism, no
clinical significant difference was found between responders
and non responder 105±48 ms vs. 135 ms respectively.
Patients with pre CRT MR had a change in ERO of 25%
(14 mm2 to 10.5 mm2).
All responders demonstrated viability in ≥4 segments
(5±1 segments). Moreover, those patients had viability in
≥2 segments in the region of the pacing lead which was not
the case in the non responder patient. The pacing lead was in
the posterior region for all patients. At peak DSE responders
showed reduction of WMSI of 13% in comparison to 3% for
the non responder patient.
4. Discussion
To the best of our knowledge, this preliminary report is
the first to address viability, particularly in the region of the
pacing lead, as a predictor of response to CRT in patients
with RBBB. Our results show that 3 patients had a response
to CRT defined by ≥15% reduction in LV end-systolic
volume. Of interest, all responders had local viability, i.e.
myocardial viability in the region of pacing lead, contrasting
with the non responder patient who had neither viability in
the region of the pacing lead or substantial global viability.
Significant electrical conduction delay (QRS≥120 ms) is
encountered in about 30% of patients with severe systolic
dysfunction. Of these patients ≥90% have LBBB. Compa-
nion trial reveals that only 10% of the 1520 patients studied
had RBBB [14]. In subgroup analysis of Companion trial,
the addition of CRT in patients with bundle branch block
other than LBBB did not resulted in significant reduction of
hazard ratios of primary end-point (death or hospitalization).
The few studies examining the role of CRT in RBBB patients
have yielded conflicting results supporting or lacking
support for CRT in this setting. Other studies, however,
have found that patients with RBBB and significant
intraventricular mechanical delay respond to CRT [8].
Recently, Byrne et al. reported in an animal model that the
magnitude of cardiac dyssynchrony in a failing heart with a
pure RBBB is considerably less than in hearts with an
LBBB, despite similar prolongation of the QRS [15]. In the
same line, Haghjoo reported that significant intraventricular
dyssynchrony was found in 63% of patients in the LBBB
group as opposed to 31% of patient in the RBBB group [16].
The mechanisms explaining CRT benefice in patient with HF
is related to reduction of LV dyssynchrony and correspond-
ing stress–strain disparities and inefficient contraction of the
ventricle; it is not surprising that in presence of less LV
asynchrony, patients with RBBB show less benefit from
CRT than patients with LBBB.
Because regional wall thickening is influenced by the
extent of myocardial fibrosis, it has been hypothesized thatPlease cite this article as: O'Connor K, et al, Usefulness of cardiac resynchron
important piece of the puzzle? Int J Cardiol (2009), doi:10.1016/j.ijcard.2008.1myocardial viability could help to predict response to CRT.
Using nuclear myocardial perfusion, magnetic resonance
imaging and DSE, studies have demonstrated the importance
of viability in predicting response to CRT [5,6,17].
Furthermore, in patients with transmural scar tissue in the
region of the LV pacing lead, CRT did not demonstrate
clinical or LV remodeling improvement at follow-up [18].
Studies evaluating the role of viability to predict response to
CRT have involved a majority of patients with LBBB. This is
the first report regarding viability as a predictor of response
in patients with RBBB. Some studies have suggested that
ischemic dilated cardiomyopathy is less likely to respond to
CRT than non ischemic dilated cardiomyopathy, whereas
other studies have not. However, these studies only
examined outcomes based on the presence or absence of
coronary artery disease as the cause of systolic heart failure.
These studies did not consider, for example, the more
specific possibility that infarct location influences CRT
response. Whether CRT is “wide right” in RBBB remains to
be determined [7]. Insufficient clinical evidences are
available to reach definitive conclusions, and this will be
difficult to overcome because of the underrepresentation of
RBBB in systolic HF. Although CRT “non response” is
likely a diverse phenomenon, there is emerging consensus
that inadequate patient selection is a key element. This
preliminary report suggests that patients with RBBB do not
derive the same degree of benefit from CRT unless
intraventricular dyssynchrony and viability in the region of
the pacing lead are present. A study designed to specifically
enroll patients with RBBB, congestive HF and significant
LV asynchrony is required. Moreover, in such population,
evidence of myocardial viability by DSE or any other
valuable method (MRI, PET scan) should also be evaluated
to find out if the criterion of viability in the region of the
pacing lead is as important in patients with RBBB than in
patients with LBBB. Such a study may identify which
patients with RBBB will derive the greatest benefit from left-
sided resynchronization.
5. Conclusion
Prospective randomized trials concluded that patients
with RBBB do not derive significant benefit from CRT.
However, in these studies, significant LV asynchrony was
not an inclusion criterion and viability in the region of the
pacing lead was not assessed. Our preliminary report
suggests that in presence of significant LV asynchrony and
viability in the region of the pacing lead, patients with RBBB
and HF may show similar LV reverse remodeling as patients
with LBBB after CRT.
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